Anand Mahadevan, M.D.
Instructor, Department of Radiation oncology, Harvard Medical School
Attending Physician, Radiation Therapy, Beth Israel Deaconess Medical Center
Contact Info
Anand Mahadevan
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA, 02215
Mailstop: FNB25
Phone: 617-667-2345
Fax: 617-667-4990
amahadev@bidmc.harvard.edu
Beth Israel Deaconess Medical Center
330 Brookline Avenue
Boston, MA, 02215
Mailstop: FNB25
Phone: 617-667-2345
Fax: 617-667-4990
amahadev@bidmc.harvard.edu
Assistant
Not Available.DF/HCC Program Affiliation
Head and Neck CancerResearch Abstract
I am the ite PI in Beth Israel Deaconess Medical Center for the two ongoing Clinical Trials in Head and Neck Cancer. One of them is a randomised Phase II trial looking at the use of subcutaneous Amifostine in patients recieving concurrent chemoradiation fot advanced Head and Neck Cancer. The Other trial is a multiinstitutional randomised trial comparing sequential versus concurrent chemotherapy with radiation in advanced Head and Neck cancerPublications
- Haddad R, Tishler RB, Norris CM, Mahadevan A, Busse P, Wirth L, Goguen LA, Sullivan CA, Costello R, Case MA, Posner MR.Docetaxel, cisplatin, 5-fluorouracil (TPF)-based induction chemotherapy for head and neck cancer and the case for sequential, combined-m
12604730




